These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 11224687

  • 1. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
    Atweh GF, Schechter AN.
    Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM, Pace B.
    Pediatr Pathol Mol Med; 2001 Mar; 20(1):87-106. PubMed ID: 12673846
    [Abstract] [Full Text] [Related]

  • 3. Therapies to increase fetal hemoglobin in sickle cell disease.
    Steinberg MH.
    Curr Hematol Rep; 2003 Mar; 2(2):95-101. PubMed ID: 12901139
    [Abstract] [Full Text] [Related]

  • 4. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
    Koshy M, Dorn L, Bressler L, Molokie R, Lavelle D, Talischy N, Hoffman R, van Overveld W, DeSimone J.
    Blood; 2000 Oct 01; 96(7):2379-84. PubMed ID: 11001887
    [Abstract] [Full Text] [Related]

  • 5. Induction of fetal hemoglobin in the treatment of sickle cell disease.
    Fathallah H, Atweh GF.
    Hematology Am Soc Hematol Educ Program; 2006 Oct 01; ():58-62. PubMed ID: 17124041
    [Abstract] [Full Text] [Related]

  • 6. Fetal hemoglobin, sickling, and sickle cell disease.
    Charache S.
    Adv Pediatr; 1990 Oct 01; 37():1-31. PubMed ID: 1702260
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov 01; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 10. Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease.
    Saunthararajah Y, DeSimone J.
    Semin Hematol; 2004 Oct 01; 41(4 Suppl 6):11-6. PubMed ID: 15534852
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Oct 01; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 12. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984 Oct 01; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS.
    Am J Pediatr Hematol Oncol; 1985 Oct 01; 7(3):258-60. PubMed ID: 2416231
    [Abstract] [Full Text] [Related]

  • 14. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease.
    Saunthararajah Y, Hillery CA, Lavelle D, Molokie R, Dorn L, Bressler L, Gavazova S, Chen YH, Hoffman R, DeSimone J.
    Blood; 2003 Dec 01; 102(12):3865-70. PubMed ID: 12907443
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Dover GJ, Charache S.
    Semin Oncol; 1992 Jun 01; 19(3 Suppl 9):61-6. PubMed ID: 1379374
    [Abstract] [Full Text] [Related]

  • 16. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia.
    DeSimone J, Koshy M, Dorn L, Lavelle D, Bressler L, Molokie R, Talischy N.
    Blood; 2002 Jun 01; 99(11):3905-8. PubMed ID: 12010787
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R, Veith R, Papayannopoulou T, Stamatoyannopoulos G.
    Prog Clin Biol Res; 1985 Jun 01; 191():433-45. PubMed ID: 2413479
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H.
    Hematology; 2004 Jun 01; 9(3):223-33. PubMed ID: 15204104
    [Abstract] [Full Text] [Related]

  • 19. Induction of fetal hemoglobin in sickle cell disease.
    Bunn HF.
    Blood; 1999 Mar 15; 93(6):1787-9. PubMed ID: 10068648
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.